Pfizer Begins COVID Vaccine Trials On Children Below 12

American Pharma Company Pfizer has now started vaccination trials on children under 12. In the first phase, they will administer the vaccine on a small number of young children. Pfizer will give different doses of vaccine to these children. The company has selected more than 4,500 children from four countries of the world. These children are from US, Finland, Poland and Spain. 

Pfizer said they have begun testing the COVID-19 vaccination on a large group of children under the age of 12. 

Vaccines Already Being Administered On Children Above 12 years of age

US and European Union have already approved Pfizer’s COVID vaccine for children over the age of 12. However, they have only got emergency approval. Pfizer made the COVID vaccine in collaboration with its German partner BioNtech. The vaccine of this company was the first to get World Health Organization’s approval.

video ads

The company said that they have started the work of selecting children aged 5 to 11 years this week for the vaccination trial. They will give these children two doses of 10 micrograms each. This dose is one-third of the vaccine dose that they were giving to adolescents and adults. A few weeks after this, the vaccine trial will be started on children above 6 months of age. They will get three micrograms of vaccine.

Many Companies Are Conducting Tests

Apart from Pfizer, Moderna is also conducting vaccine trials on 12-17-year-olds. The results may come out soon. The special thing is that the FDA has given permission to test the vaccine on children up to 11 years old. They have expressed confidence in the results of both the companies so far. Last month, AstraZeneca launched a study in the UK on children aged 6 to 17 years. At the same time, Johnson & Johnson is also studying. Meanwhile, China’s Sinovac has also described its vaccine as effective on children up to three years old.